Market Research Logo

Naloxone Market - Size, Share, Outlook, and Opportunity Analysis 2018-2026

Naloxone Market - Size, Share, Outlook, and Opportunity Analysis 2018-2026

Naloxone is an opioid antagonist used to counter the effects of opioid overdose, such as morphine and heroine. Naloxone is indicated for use in opioid overdose to counteract life-threatening depression of the central nervous system and respiratory system, allowing an overdose victim to breathe normally. Naloxone is non-scheduled prescription medication, which in most cases, is administrated by emergency response personnel or minimally trained personnel, and is thus ideal for treating overdose in people who are prescribed opioid pain medication. Naloxone can be administrated through parenteral route, by injecting in the muscle or vein.
Market Dynamics
Increasing launches and approval of new naloxone products in the market is expected to drive the global naloxone market growth over the forecast period. In October, 2016 Health Canada approved Narcan Nasal Spray 4 mg for non-prescription, community use in Canada
Rising prevalence of opioid overdose in key regions such as North America, and Europe is expected to drive demand for naloxone products and drive the naloxone market growth in the near future. For instance, according to the data published by European Monitoring Center for Drugs and Drug Addiction (EMCDDA), in 2016, around 150,943 high-risk opioid users were reported in Germany and around 330,445 were reported in the U.K.
Furthermore, initiatives by various government and private organizations to increase access of naloxone product among the population is also expected to drive market growth. For instance, in 2015, Kaleo, Inc. partnered with the Clinton Foundation and provided bulk discounts on its EVZIO to various college universities and public safety organizations.
Key features of the study:

This report provides in-depth analysis of naloxone market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global naloxone market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., and Kern Pharma, S.L.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global naloxone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the naloxone market

Detailed Segmentation:

Global Naloxone Market, By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

Global Naloxone Market, By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

Global Naloxone Market, By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

Global Naloxone Market, By Geography:

North America

By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

By Country:

U.S.
Canada

Europe

By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Latin America

By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Middle East

By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

By Country:

GCC
Israel
Rest of Middle East

Africa

By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

By Country:

Central Africa
South Africa
North Africa

Company Profiles

Mylan N.V.*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

Novartis AG
Indivior Plc.
Adapt Pharma, Inc.
Amphastar Pharmaceuticals, Inc.
INSYS Therapeutics, Inc.
Mundipharma International Limited
Kaleo, Inc.
Kern Pharma, S.L.

“*” marked represents similar segmentation in other categories in the respective section.


Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Strength
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Product Approvals/Launch
Pipeline Analysis
Regulatory Scenario
Reimbursement Scenario
Dosage Variation
Pricing Analysis
Supply Chain Analysis
Global Naloxone Market, By Strength, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
0.4 mg/ml
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
1mg/ml
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
0.4mg/0.4ml
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
4mg/0.1ml and Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Global Naloxone Market, By Route of Administration, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
Intranasal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Intramuscular/Subcutaneous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Intravenous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Global Naloxone Market, By Distribution Channel, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Global Naloxone Market, By Region, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
North America
Market Size and Forecast, By Strength, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
U.S.
Canada
Europe
Market Size and Forecast, By Strength, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Strength, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Strength, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Strength, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
Central Africa
South Africa
North Africa
Middle East
Market Size and Forecast, By Strength, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
GCC
Israel
Rest of Middle East
Competitive Landscape
Heat Map Analysis
Company Profiles
Mylan N.V.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Indivior Plc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Adapt Pharma, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Amphastar Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
INSYS Therapeutics, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Mundipharma International Limited
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Kaleo, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Kern Pharma, S.L.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Section
References
Research Methodology
About us and Sales Contact
*Browse 47 market data tables and 33figures on “Naloxone Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report